Autor/in / Beteiligte Person: |
Harris, WS ; Tintle, NL ; Imamura, F ; Qian, F ; Korat, AVA ; Marklund, M ; Djoussé, L ; Bassett, JK ; Carmichael, PH ; Chen, YY ; Hirakawa, Y ; Küpers, LK ; Laguzzi, F ; Lankinen, M ; Murphy, RA ; Samieri, C ; Senn, MK ; Shi, P ; Virtanen, JK ; Brouwer, IA ; Chien, KL ; Eiriksdottir, G ; Forouhi, NG ; Geleijnse, JM ; Giles, GG ; Gudnason, V ; Helmer, C ; Hodge, A ; Jackson, R ; Khaw, KT ; Laakso, M ; Lai, H ; Laurin, D ; Leander, K ; Lindsay, J ; Micha, R ; Mursu, J ; Ninomiya, T ; Post, W ; Psaty, BM ; Risérus, U ; Robinson, JG ; Shadyab, AH ; Snetselaar, L ; Sala-Vila, A ; Sun, Y ; Steffen, LM ; Tsai, MY ; Wareham, NJ ; Wood, AC ; Wu, JHY ; Hu, F ; Sun, Q ; Siscovick, DS ; Lemaitre, RN ; Mozaffarian, D |
Sonstiges: |
- Nachgewiesen in: MEDLINE
- Sprachen: English
- Corporate Authors: Fatty Acids and Outcomes Research Consortium (FORCE)
- Publication Type: Journal Article; Meta-Analysis
- Language: English
- [Nat Commun] 2021 Apr 22; Vol. 12 (1), pp. 2329. <i>Date of Electronic Publication: </i>2021 Apr 22.
- MeSH Terms: Cause of Death* ; Mortality, Premature* ; Fatty Acids, Omega-3 / *blood ; Aged ; Aged, 80 and over ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Prospective Studies ; Protective Factors ; Risk Factors
- References: Dyerberg, J., Bang, H. O., Stoffersen, E., Moncada, S. & Vane, J. R. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet 2, 117–119 (1978). ; Bang, H. O. & Dyerberg, J. Lipid metabolism and ischemic heart disease in greenland eskimos. Adv. Nutr. Res. 3, 1–22 (1980). ; Hu, Y., Hu, F. B. & Manson, J. E. Marine omega-3 supplementation and cardiovascular disease: an updated meta-analysis of 13 randomized controlled trials involving 127 477 participants. J. Am. Heart Assoc. 8, e013543 (2019). (PMID: 31567003680602810.1161/JAHA.119.013543) ; Del Gobbo, L. C. et al. Omega-3 polyunsaturated fatty acid biomarkers and coronary heart disease: pooling project of 19 cohort studies. JAMA Intern. Med. 176, 1155–1166 (2016). (PMID: 27357102518353510.1001/jamainternmed.2016.2925) ; Wan, Y., Zheng, J., Wang, F. & Li, D. Fish, long chain omega-3 polyunsaturated fatty acids consumption, and risk of all-cause mortality: a systematic review and dose-response meta-analysis from 23 independent prospective cohort studies. Asia Pac. J. Clin. Nutr. 26, 939–956 (2017). (PMID: 28802305) ; Wang, D. D. et al. Association of specific dietary fats with total and cause-specific mortality. JAMA Intern. Med. 176, 1134–1145 (2016). (PMID: 27379574512377210.1001/jamainternmed.2016.2417) ; Jackson, K. H., Polreis, J. M., Tintle, N. L., Kris-Etherton, P. M. & Harris, W. S. Association of reported fish intake and supplementation status with the omega-3 index. Prostaglandins Leukotrienes Essent. Fat. Aacids 142, 4–10 (2019). (PMID: 10.1016/j.plefa.2019.01.002) ; Barcelo-Coblijn, G. & Murphy, E. J. Alpha-linolenic acid and its conversion to longer chain n-3 fatty acids: benefits for human health and a role in maintaining tissue n-3 fatty acid levels. Prog. Lipid Res. 48, 355–374 (2009). (PMID: 1961958310.1016/j.plipres.2009.07.002) ; Harris, W. S. et al. Red blood cell polyunsaturated fatty acids and mortality in the Women’s Health Initiative Memory Study. J. Clin. Lipidol. 11, 250–259 (2017). (PMID: 28391893556338210.1016/j.jacl.2016.12.013) ; Harris, W. S., Tintle, N. L., Etherton, M. R. & Vasan, R. S. Erythrocyte long-chain omega-3 fatty acid levels are inversely associated with mortality and with incident cardiovascular disease: the Framingham Heart Study. J. Clin. Lipidol. 12, 718–724 (2018). (PMID: 29559306603462910.1016/j.jacl.2018.02.010) ; Mozaffarian, D. et al. Plasma phospholipid long-chain omega-3 fatty acids and total and cause-specific mortality in older adults: a cohort study. Ann. Intern. Med. 158, 515–525 (2013). (PMID: 23546563369884410.7326/0003-4819-158-7-201304020-00003) ; Iggman, D., Arnlov, J., Cederholm, T. & Riserus, U. Association of adipose tissue fatty acids with cardiovascular and all-cause mortality in elderly men. JAMA Cardiol. 1, 745–753 (2016). (PMID: 2754168110.1001/jamacardio.2016.2259) ; Chien, K. L. et al. Comparison of predictive performance of various fatty acids for the risk of cardiovascular disease events and all-cause deaths in a community-based cohort. Atherosclerosis 230, 140–147 (2013). (PMID: 2395826610.1016/j.atherosclerosis.2013.06.015) ; Lai, H. T. et al. Serial circulating omega 3 polyunsaturated fatty acids and healthy ageing among older adults in the Cardiovascular Health Study: prospective cohort study. Br. Med. J. 363, k4067 (2018). (PMID: 10.1136/bmj.k4067) ; FORCE. Fatty Acids and Outcomes Research Consortium. http://force.nutrition.tufts.edu/ (2020). ; Miura, K., Hughes, M. C. B., Ungerer, J. P. & Green, A. C. Plasma eicosapentaenoic acid is negatively associated with all-cause mortality among men and women in a population-based prospective study. Nutr. Res. 36, 1202–1209 (2016). (PMID: 2786561410.1016/j.nutres.2016.09.006) ; Lindberg, M., Saltvedt, I., Sletvold, O. & Bjerve, K. S. Long-chain n-3 fatty acids and mortality in elderly patients. Am. J. Clin. Nutr. 88, 722–729 (2008). (PMID: 1877928910.1093/ajcn/88.3.722) ; Kleber, M. E., Delgado, G. E., Lorkowski, S., Marz, W. & von Schacky, C. Omega-3 fatty acids and mortality in patients referred for coronary angiography. The Ludwigshafen Risk and Cardiovascular Health Study. Atherosclerosis 252, 175–181 (2016). (PMID: 2739773410.1016/j.atherosclerosis.2016.06.049) ; Chen, G. C., Yang, J., Eggersdorfer, M., Zhang, W. & Qin, L. Q. N-3 long-chain polyunsaturated fatty acids and risk of all-cause mortality among general populations: a meta-analysis. Sci. Rep. 6, 28165 (2016). (PMID: 27306836491013210.1038/srep28165) ; Matsuda, H. et al. Evaluation of a high serum docosahexaenoic acid level as a predictor of longevity among elderly residents at a special nursing home. Geriatr. Gerontol. Int. 18, 980–982 (2018). (PMID: 2992449310.1111/ggi.13297) ; Wang, Y. et al. Fish consumption, blood docosahexaenoic acid and chronic diseases in Chinese rural populations. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 136, 127–140 (2003). (PMID: 1452763510.1016/S1095-6433(03)00016-3) ; Otsuka, R. et al. Fish and meat intake, serum eicosapentaenoic acid and docosahexaenoic acid levels, and mortality in community-dwelling Japanese Older Persons. Int. J. Environ. Res. Public Health 16, 1806 (2019). (PMID: 657251810.3390/ijerph16101806) ; Virtanen, J. K. et al. Mercury, fish oils, and risk of acute coronary events and cardiovascular disease, coronary heart disease, and all-cause mortality in men in eastern Finland. Arterioscler. Thromb. Vasc. Biol. 25, 228–233 (2005). (PMID: 1553962510.1161/01.ATV.0000150040.20950.61) ; Pottala, J. V., Garg, S., Cohen, B. E., Whooley, M. A. & Harris, W. S. Blood eicosapentaenoic and docosahexaenoic acids predict all-cause mortality in patients with stable coronary heart disease: the Heart and Soul Study. Circ. Cardiovasc. Qual. Outcomes 3, 406–412 (2010). (PMID: 20551373305860110.1161/CIRCOUTCOMES.109.896159) ; Zhang, Y. et al. Association of fish and long-chain omega-3 fatty acids intakes with total and cause-specific mortality: prospective analysis of 421 309 individuals. J. Intern. Med. 284, 399–417 (2018). (PMID: 3001939910.1111/joim.12786) ; Bell, G. A. et al. Intake of long-chain omega-3 fatty acids from diet and supplements in relation to mortality. Am. J. Epidemiol. 179, 710–720 (2014). (PMID: 24496442393984910.1093/aje/kwt326) ; Li, Z.-H. et al. Associations of habitual fish oil supplementation with cardiovascular outcomes and all cause mortality: evidence from a large population based cohort study. Br. Med. J. 368, m456 (2020). (PMID: 10.1136/bmj.m456) ; Pan, A. et al. α-Linolenic acid and risk of cardiovascular disease: a systematic review and meta-analysis. Am. J. Clin. Nutr. 96, 1262–1273 (2012). (PMID: 23076616349792310.3945/ajcn.112.044040) ; Darwesh, A. M., Sosnowski, D. K., Lee, T. Y., Keshavarz-Bahaghighat, H. & Seubert, J. M. Insights into the cardioprotective properties of n-3 PUFAs against ischemic heart disease via modulation of the innate immune system. Chemistry 308, 20–44 (2019). ; Wu, J. H. Y., Micha, R. & Mozaffarian, D. Dietary fats and cardiometabolic disease: mechanisms and effects on risk factors and outcomes. Nat. Rev. Cardiol. 16, 581–601 (2019). (PMID: 3109779110.1038/s41569-019-0206-1) ; Endo, J. & Arita, M. Cardioprotective mechanism of omega-3 polyunsaturated fatty acids. J. Cardiol. 67, 22–27 (2016). (PMID: 2635971210.1016/j.jjcc.2015.08.002) ; Serhan, C. N., Dalli, J., Colas, R. A., Winkler, J. W. & Chiang, N. Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome. Biochim. Biophys. Acta 1851, 397–413 (2015). (PMID: 2513956210.1016/j.bbalip.2014.08.006) ; Farzaneh-Far, R., Harris, W. S., Garg, S., Na, B. & Whooley, M. A. Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: the Heart and Soul Study. Atherosclerosis 205, 538–543 (2009). (PMID: 1918529910.1016/j.atherosclerosis.2008.12.013) ; Chen, Z. et al. mTORC1/2 targeted by n-3 polyunsaturated fatty acids in the prevention of mammary tumorigenesis and tumor progression. Oncogene 33, 4548–4557 (2014). (PMID: 2409648210.1038/onc.2013.402) ; Liu, R. et al. High ratio of ω-3/ω-6 polyunsaturated fatty acids targets mTORC1 to prevent high-fat diet-induced metabolic syndrome and mitochondrial dysfunction in mice. J. Nutr. Biochem. 79, 108330 (2020). (PMID: 3217940810.1016/j.jnutbio.2019.108330) ; Nie, J. et al. Inhibition of mammalian target of rapamycin complex 1 signaling by n-3 polyunsaturated fatty acids promotes locomotor recovery after spinal cord injury. Mol. Med. Rep. 17, 5894–5902 (2018). (PMID: 294366955866035) ; Deyama, S. et al. Resolvin D1 and D2 reverse lipopolysaccharide-induced depression-like behaviors through the mTORC1 signaling pathway. Int. J. Neuropsychopharmacol. 20, 575–584 (2017). (PMID: 28419244549278010.1093/ijnp/pyx023) ; Papadopoli, D. et al. mTOR as a central regulator of lifespan and aging. F1000Res 8, 998 (2019). (PMID: 10.12688/f1000research.17196.1) ; Bjedov, I. & Rallis, C. The target of rapamycin signalling pathway in ageing and lifespan regulation. Genes 11, 1043 (2020). (PMID: 756555410.3390/genes11091043) ; Farzaneh-Far, R. et al. Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease. J. Am. Med. Assoc. 303, 250–257 (2010). (PMID: 10.1001/jama.2009.2008) ; Bernadotte, A., Mikhelson, V. M. & Spivak, I. M. Markers of cellular senescence. Telomere shortening as a marker of cellular senescence. Aging 8, 3–11 (2016). (PMID: 26805432476170910.18632/aging.100871) ; Arbeev, K. G. et al. Association of leukocyte telomere length with mortality among adult participants in 3 longitudinal studies. JAMA Netw. Open 3, e200023 (2020). (PMID: 32101305713769010.1001/jamanetworkopen.2020.0023) ; Bernasconi, A. A., Wiest, M. M., Lavie, C. J., Milani, R. V. & Laukkanen, J. A. Effect of omega-3 dosage on cardiovascular outcomes: an updated meta-analysis and meta-regression of Interventional Trials. Mayo Clin. Proc. 96, 304–313 (2021). (PMID: 3295185510.1016/j.mayocp.2020.08.034) ; Nicholls, S. J. et al. Effect of high-dose omega-3 fatty acids vs corn oil on major adverse cardiovascular events in patients at high cardiovascular risk: the STRENGTH Randomized Clinical Trial. J. Am. Med. Assoc. 324, 2268–2280 (2020). (PMID: 10.1001/jama.2020.22258) ; Zhang, Z. et al. Poultry and fish consumption in relation to total cancer mortality: a meta-analysis of prospective studies. Nutr. Cancer 70, 204–212 (2018). (PMID: 2927894010.1080/01635581.2018.1412474) ; Zhang, Y. F., Gao, H. F., Hou, A. J. & Zhou, Y. H. Effect of omega-3 fatty acid supplementation on cancer incidence, non-vascular death, and total mortality: a meta-analysis of randomized controlled trials. BMC Public Health 14, 204 (2014). (PMID: 24568238393802810.1186/1471-2458-14-204) ; Manson, J. E. et al. Marine n-3 fatty acids and prevention of cardiovascular disease and cancer. N. Engl. J. Med. 380, 23–32 (2019). (PMID: 3041563710.1056/NEJMoa1811403) ; Richter, C. K. et al. n-3 Docosapentaenoic acid intake and relationship with plasma long-chain n-3 fatty acid concentrations in the United States: NHANES 2003-2014. Lipids 54, 221–230 (2019). (PMID: 31025717668181910.1002/lipd.12146) ; Drouin, G., Rioux, V. & Legrand, P. The n-3 docosapentaenoic acid (DPA): a new player in the n-3 long chain polyunsaturated fatty acid family. Biochimie 159, 36–48 (2019). (PMID: 3071635810.1016/j.biochi.2019.01.022) ; Meyer, B. J. & Groot, R. H. M. Effects of omega-3 long chain polyunsaturated fatty acid supplementation on cardiovascular mortality: the importance of the dose of DHA. Nutrients 9, 1305 (2017). (PMID: 574875510.3390/nu9121305) ; von Schacky, C. Meta-analysing randomised controlled trials with omega-3 fatty acids in cardiovascular disease. Evid. Based Med. 18, e33 (2013). (PMID: 10.1136/eb-2012-100960) ; Rice, H. B. et al. Conducting omega-3 clinical trials with cardiovascular outcomes: proceedings of a workshop held at ISSFAL 2014. Prostaglandins Leukotrienes Essent. Fat. Acids 107, 30–42 (2016). (PMID: 10.1016/j.plefa.2016.01.003) ; U.S. Department of Agriculture, A.R.S. Dietary Guidelines for Americans 2015–2020. https://www.dietaryguidelines.gov/current-dietary-guidelines/2015-2020-dietary-guidelines (2015). ; Bhatt, D. L. et al. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. N. Engl. J. Med. 380, 11–22 (2019). (PMID: 3041562810.1056/NEJMoa1812792) ; Kalstad, A. A. et al. Effects of n-3 fatty acid supplements in elderly patients after myocardial infarction: a randomized controlled trial. Circulation 143, 528–539 (2021). (PMID: 3319177210.1161/CIRCULATIONAHA.120.052209) ; Harris, W. S., Pottala, J. V., Vasan, R. S., Larson, M. G. & Robins, S. J. Changes in erythrocyte membrane trans and marine fatty acids between 1999 and 2006 in older Americans. J. Nutr. 142, 1297–1303 (2012). (PMID: 22623386337466810.3945/jn.112.158295) ; Flock, M. R. et al. Determinants of erythrocyte omega-3 fatty acid content in response to fish oil supplementation: a dose-response randomized controlled trial. J. Am. Heart Assoc. 2, e000513 (2013). (PMID: 24252845388674410.1161/JAHA.113.000513) ; Young, A. J. et al. Blood fatty acid changes in healthy young Americans in response to a 10-week diet that increased n-3 and reduced n-6 fatty acid consumption: a randomised controlled trial. Br. J. Nutr. 117, 1257–1269 (2017). ; Arab, L. Biomarkers of fat and fatty acid intake. J. Nutr. 133, 925S–932S (2003). (PMID: 1261217810.1093/jn/133.3.925S) ; Hodson, L., Skeaff, C. M. & Fielding, B. A. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog. Lipid Res. 47, 348–380 (2008). (PMID: 1843593410.1016/j.plipres.2008.03.003) ; Siscovick, D. S. et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. J. Am. Med. Assoc. 274, 1363–1367 (1995). (PMID: 10.1001/jama.1995.03530170043030) ; Albert, C. M. et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N. Engl. J. Med. 346, 1113–1118 (2002). (PMID: 1194827010.1056/NEJMoa012918) ; Harris, T. B. et al. Age, gene/environment susceptibility–Reykjavik study: multidisciplinary applied phenomics. Am. J. Epidemiol. 165, 1076–1087 (2007). (PMID: 17351290272394810.1093/aje/kwk115) ; Orsini, N., Li, R., Wolk, A., Khudyakov, P. & Spiegelman, D. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am. J. Epidemiol. 175, 66–73 (2011). (PMID: 22135359324460810.1093/aje/kwr265) ; Viechtbauer, W. Conducting meta-analyses in R with the metafor Package. J. Stat. Softw. 36, 48 (2010). (PMID: 10.18637/jss.v036.i03) ; Team, R. C. R.: a language and environment for statistical computing. https://www.R-project.org/ (2019).
- Grant Information: MC_UU_00006/1 United Kingdom MRC_ Medical Research Council; MC_UU_12015/1 United Kingdom MRC_ Medical Research Council; T32 CA009001 United States CA NCI NIH HHS; MC_UU_12015/5 United Kingdom MRC_ Medical Research Council; MC_UU_00006/3 United Kingdom MRC_ Medical Research Council
- Substance Nomenclature: 0 (Fatty Acids, Omega-3)
- Entry Date(s): Date Created: 20210423 Date Completed: 20210511 Latest Revision: 20230201
- Update Code: 20240513
- PubMed Central ID: PMC8062567
|